Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03370185
Title Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

chronic lymphocytic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Duvelisib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Tempe Arizona 85284 United States Details
Genesis Cancer Center Hot Springs Arkansas 71913 United States Details
Moores UC San Diego Cancer Center La Jolla California 92093 United States Details
Ingalls Memorial Hospital Harvey Illinois 60426 United States Details
QUEST Research Institute Royal Oak Michigan 48073 United States Details
St. Vincent Frontier Cancer Center Billings Montana 59102 United States Details
Summit Medical Group Morristown New Jersey 07932 United States Details
Medical Oncology Associates PS, WA Spokane Washington 99208 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field